ATE376839T1 - Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutisches kit zur verwendung in diesem verfahren - Google Patents

Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutisches kit zur verwendung in diesem verfahren

Info

Publication number
ATE376839T1
ATE376839T1 AT02792102T AT02792102T ATE376839T1 AT E376839 T1 ATE376839 T1 AT E376839T1 AT 02792102 T AT02792102 T AT 02792102T AT 02792102 T AT02792102 T AT 02792102T AT E376839 T1 ATE376839 T1 AT E376839T1
Authority
AT
Austria
Prior art keywords
substance
progestogen
precursor
administration
parenteral
Prior art date
Application number
AT02792102T
Other languages
English (en)
Inventor
Bennink Herman Coelingh
Evert Bunschoten
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Application granted granted Critical
Publication of ATE376839T1 publication Critical patent/ATE376839T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02792102T 2001-12-21 2002-12-20 Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutisches kit zur verwendung in diesem verfahren ATE376839T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01205068 2001-12-21

Publications (1)

Publication Number Publication Date
ATE376839T1 true ATE376839T1 (de) 2007-11-15

Family

ID=8181501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02792102T ATE376839T1 (de) 2001-12-21 2002-12-20 Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutisches kit zur verwendung in diesem verfahren

Country Status (7)

Country Link
US (1) US20060217315A1 (de)
EP (2) EP1455831B1 (de)
AT (1) ATE376839T1 (de)
AU (1) AU2002358346A1 (de)
CA (1) CA2471388A1 (de)
DE (1) DE60223284T2 (de)
WO (1) WO2003055524A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA009371B1 (ru) 2002-06-07 2007-12-28 Арес Трейдинг С.А. Способ управляемой гиперстимуляции яичников и фармацевтический набор для использования в таком способе
GB0214793D0 (en) * 2002-06-26 2002-08-07 Disperse Technologies Plc Biliquid foam entrapment
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
EP2717880B1 (de) 2011-06-13 2016-12-14 Parthenogen SAGL Selektive zns-freisetzung von mifepriston (ru486) zur modulierung des zeitpunktes des spontanen lh-ansteigs während follikularer stimulationszyklen
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
FR2999081B1 (fr) * 2012-12-06 2015-02-27 Hra Pharma Lab Dispersion solide d'un modulateur selectif du recepteur a la progesterone
CA2905214A1 (en) 2013-03-14 2014-09-18 Laboratoire Hra-Pharma Method for scheduling ovulation
RU2603319C1 (ru) * 2015-09-09 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения больных с тяжелыми формами синдрома гиперстимуляции яичников
WO2021133430A1 (en) * 2019-12-23 2021-07-01 Augusta University Research Institute, Inc. Progesterone formulation to trigger ovulation and provide luteal phase support

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651435A1 (fr) * 1989-09-07 1991-03-08 Roussel Uclaf Nouvelle utilisation de composes anti-progestomimetiques.

Also Published As

Publication number Publication date
EP1455831A1 (de) 2004-09-15
US20060217315A1 (en) 2006-09-28
DE60223284T2 (de) 2008-07-31
EP1455831B1 (de) 2007-10-31
CA2471388A1 (en) 2003-07-10
AU2002358346A1 (en) 2003-07-15
DE60223284D1 (de) 2007-12-13
WO2003055524A1 (en) 2003-07-10
EP1862182A2 (de) 2007-12-05

Similar Documents

Publication Publication Date Title
TAKETANI et al. Epidermal growth factor stimulates cell proliferation and inhibits functional differentiation of mouse mammary epithelial cells in culture
WEISS et al. Thyrotropin-stimulated iodide transport mediated by adenosine 3′ 5′-monophosphate and dependent on protein synthesis
Rechler et al. Interaction of multiplication-stimulating activity with chick embryo fibroblasts demonstrates a growth receptor
Saperas et al. Central action of recombinant interleukin-1 to inhibit acid secretion in rats
ATE376839T1 (de) Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutisches kit zur verwendung in diesem verfahren
González-Manchón et al. Activin-A modulates gonadotropin-releasing hormone secretion from a gonadotropin-releasing hormone-secreting neuronal cell line
Zelinski-Wooten et al. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function
HUP0302026A2 (hu) Növekedési hormon szekrécióját fokozó triptofánszármazékok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
IL138319A0 (en) MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
Denko A role for neuropeptides in inflammation
ATE468109T1 (de) Liposomale abgabe von verbindungen auf vitamin-e- basis
HUP0001922A2 (hu) Pirazolo[4,3-c]-piridin származékok, ezeket tartalmazó inzulinrezisztencia elleni gyógyszerkészítmények, intermedierek és eljárás előállításukra
Gessl et al. Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein
WO2003103770A3 (en) METHOD OF CONTROLLED OVARIAN HYPERSTIMULATION AND PAHRMACEUTICAL KIT FOR THIS USE
Hanna et al. Phosphodiesterase 3 (PDE3) inhibition with cilostazol does not block in vivo oocyte maturation in rhesus macaques (Macaca mulatta)
Kanamori et al. Gonadotropin receptors in the postovulatory ovary of amago salmon (Oncorhynchus rhodurus)
US20110281802A1 (en) Composition for treatment and prevention of hair loss and premature graying of hair
Pekary et al. Circadian rhythms of TRH-like peptide levels in rat brain
ATE491464T1 (de) Lh zur verwendung der erhaltung einer oder mehreren schwangerschaften durch induktion der bildung des sekundären gelbkörpers.
ES2543198T3 (es) Mutantes de FSH
Whybrow et al. Neuroendocrine mediating mechanisms: From the symbolic stimulus to the physiological response
SOWERS et al. Prolactin response to N3im-methyl-thyrotropin releasing hormone in euthyroid subjects
Binet et al. Calcitonin-responsive adenylate cyclase in cultured F9 embryonal carcinoma cells
Koizumi The role of the hypothalamus in neuroendocrinology
Magnusson et al. Oxygen consumption by rat oocytes and cumulus cells during induced atresia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1455831

Country of ref document: EP

REN Ceased due to non-payment of the annual fee